University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Red Brentuximab injection

National CDF list. For hospital use only.

Status: Green Brevinor

Umbrella service only

Status: Amber Brinzolamide 1% and Brimonidine 0.2% eye drops (Simbrinza)

Specialist ophthalmologist recommendation

Status: Amber Brinzolamide eye drops

Specialist ophthalmologist recommendation

Status: Amber Brivaracetam (Briviact®)

Initiation by a suitable specialist on the recommendation of a tertiary epilepsy specialist with ongoing shared care between primary care and a suitable specialist.For adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adult and adolescent patients from 16 years of age with severe refractory epilepsy warranting tertiary specialist input for patients who have tried three or more AEDs. The patient has used levetiracetam and has documentation of intolerance and patient is using a third line agent (perampanel, zonisamide, lacosamide, eslicarbazepine) which would be replaced by brivaracetam. ESCA required

Brivacetam ESCA

Status: Amber Bromonidine eye drops

Specialist ophthalmologist recommendation

Status: Green Budenoside and Formoterol (Symbicort)

For asthma only. Non-formulary for COPD.

Status: Amber Budesonide (Budenofalk® ) Suppositories

Specialist recommendation

Status: Amber Budesonide 2mg rectal foam (2mg per 1 metered dose) (Budenofalk®)

Approved to support the shortage of Colifoam (June 2018)

Status: Amber Budesonide capsules (Budenofalk capsules 3mg)

Consultant initiation only

Building healthier lives
Back to top